Anti-VEGF versus dexamethasone implant (Ozurdex) for the management of Centre involved Diabetic Macular Edema (CiDME): a randomized study

Ashish Sharma,Keerthi Bellala,Pankaj Dongre,Prahalad Reddy

Anti-VEGF versus dexamethasone implant (Ozurdex) for the management of Centre involved Diabetic Macular Edema (CiDME): a randomized study

2019

Ashish Sharma
Keerthi Bellala
Pankaj Dongre
Prahalad Reddy

Purpose To compare the efficacy and safety of intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection versus dexamethasone implant (Ozurdex) for the treatment of center-involved DME (CiDME).

Keywords:

Ophthalmology
Dexamethasone
VEGF receptors
Macular edema
Surgery
Randomized controlled trial
Diabetes mellitus
Implant
Growth factor
Medicine
Ranibizumab
Bevacizumab
Group B
Adverse effect
Visual acuity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations